Skip to content

Study on clinical standardized therapeutic regimen and evaluation system of traditional Chinese medicine rehabilitation in post stroke cognitive impairment

Study on clinical standardized therapeutic regimen and evaluation system of traditional Chinese medi

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004872
Enrollment
Unknown
Registered
2014-06-23
Start date
2014-07-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Intervention group:basic treatment +therapeutic regimen of TCM rehabi
Control group:basic treatment +therapeutic regimen of TCM rehabi

Sponsors

Fujian University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Signed informed consent himself (herself) or his (her) immediate family member; 2.Diagnosed with stroke according to the criteria of Diagnostic Criteria for All Kinds of Cerebrovascular Disease (made by the fourth national academic conference on cerebrovascular disease, 1995), and confirmed by CT or MRI; 3.According to the Mini-Mental Status Examination (MMSE) screening: scores less than 24; 4.History of first stroke and within one year poststroke; 5.Age between 45 and 75 years; 6.The patients should be conscious, with stable vital signs.

Exclusion criteria

Exclusion criteria: 1.Patients who suffer from brain tumor, brain trauma, brain parasite disease or other diseases that could cause cognitive dysfunction; 2.Patients with severe language, vision, auditory impairment or neuropsychiatric disorder precluding cognitive examine; 3.Patients who suffer from diseases related to cognitive impairment confirmed by anamnesis, doctors or families or with history of the cognitive drug before stroke; 4.Beck Depression Scale (BDI) more than 13; 5.Patients with alcohol or drug abuse; 6.With serious illnesses, such as heart, liver, kidney, endocrine diseases and hematopoietic system disease; 7.Pregnant woman or suckling period woman; 8.Patients who are included in other clinical trials that would affect the evaluation results of this study.

Design outcomes

Primary

MeasureTime frame
Cognitive functio;

Secondary

MeasureTime frame
cognition-related brain function;Activities of Daily Living;Quality of life;Motor assessment;Safety indicators;Indicators of health economic;

Countries

China

Contacts

Public ContactLidian Chen
cld@fjtcm.edu.cn+86 0591-22861989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 4, 2026